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Summary
Background:  Left  ventricular  diastolic  dysfunction  (LVDD)  plays  an  important  role  in  heart  failure
with normal  left  ventricular  ejection  fraction  (LVEF).  Obesity  is  one  of  the  major  comorbid  con-
ditions of  LVDD.  Pericardial  fat  (PF)  is  an  ectopic  fat  depot  with  possible  paracrine  or  mechanical
effects on  the  coronary  circulation  and  myocardial  function.
Methods:  We  measured  PF  volume  on  64  slice  computed  tomography  and  analyzed  echocardio-
graphic parameters  to  conﬁrm  LVDD  in  229  consecutive  patients  suspected  of  coronary  artery
disease with  LVEF  of  more  than  50%  and  no  symptomatic  heart  failure  (59%  men,  67  ±  12  years).
LVDD was  deﬁned  as  the  ratio  of  transmitral  Doppler  early  ﬁlling  velocity  to  tissue  Doppler  early
diastolic mitral  annular  velocity  (E/e′)  >10.
Results:  PF  volume  correlated  signiﬁcantly  with  E/e′ (r  =  0.21,  p  <  0.01),  left  ventricular  mass
index (r  =  0.23,  p  <  0.001),  and  left  atrial  diameter  (r  =  0.32,  p  <  0.001).  The  mean  PF  volume  was
signiﬁcantly  greater  in  patients  with  LVDD  (184  ±  61  cm3,  n  =  141)  than  in  those  without  LVDD
 Clinical trial registration: https://center.umin.ac.jp;  ID: UMIN000001581.
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(154  ±  58,  n  =  88,  p  <  0.001).  Mult
correlated  signiﬁcantly  with  the  
volume,  p  =  0.02)  independent  of  
Conclusions:  PF  volumes  are  sig
such as  hypertension  or  diabetes.
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Introduction
Increasing  evidence  suggests  that  approximately  half  of  all
patients  with  heart  failure  have  a  normal  left  ventricular
ejection  fraction  (LVEF)  [1],  and  the  mortality  rate  for  this
group  is  similar  to  those  with  heart  failure  and  reduced  LVEF
[2].  Left  ventricular  diastolic  dysfunction  (LVDD)  plays  an
important  role  in  heart  failure  with  normal  ejection  fraction
(EF)  [3].  However,  there  is  no  speciﬁc  therapeutic  strategy
for  LVDD  partly  because  of  the  lack  of  understanding  of  its
pathophysiological  mechanism(s).
LVDD  is  most  prevalent  among  elderly  obese  women  with
hypertension,  diabetes,  coronary  artery  disease,  and/or
atrial  ﬁbrillation  [4,5]. Obesity  is  one  of  the  important  fea-
tures  of  LVDD  and  fat  tissue  is  known  to  secrete  many
adipokines  that  have  local  and  systemic  effects  on  the
cardiovascular  system  [6].  Ectopic  fat  depots  in  muscle,
liver,  and  pancreas  are  described  as  lipotoxic  and  peri-
cardial  fat  (PF)  is  recognized  as  an  ectopic  visceral  fat
depot  in  close  proximity  to  the  myocardium  and  coro-
nary  arteries.  PF  volume  is  increased  in  obese  patients
and  correlates  with  the  presence  [7,8]  and  incidence  [9]
of  coronary  atherosclerosis  independent  of  other  risk  fac-
tors,  indicating  that  PF  may  have  paracrine  or  mechanical
effects  on  the  coronary  circulation  and  myocardium.  PF  vol-
ume  has  also  been  reported  to  correlate  with  left  atrial
diameter,  which  is  an  indirect  structural  parameter  of
LVDD  [10—12]. However,  there  is  currently  no  report  of  a
functional  parameter  of  LVDD  by  tissue  Doppler  echocar-
diography  that  correlates  with  PF  volume.  The  purpose  of
this  study  was  to  assess  the  association  between  PF  volume
and  LVDD,  as  determined  by  tissue  Doppler  echocardiogra-
phy.
Methods
Study  sample
We  analyzed  consecutive  inpatients  in  a  stable  condi-
tion  who  underwent  64-slice  computed  tomography  (CT)
coronary  angiography  and  echocardiography  between  2006
and  2009  on  suspicion  of  coronary  artery  disease.  None
of  the  patients  had  history  of  previous  thoracic  surgery,
percutaneous  coronary  intervention,  or  symptomatic  heart
failure.  We  screened  304  patients,  each  with  LVEF  more
than  50%,  and  excluded  those  with  previous  pacemaker
implantation  (n  =  19),  chronic  atrial  ﬁbrillation  (n  =  12),
end-stage  renal  disease  (n  =  14),  signiﬁcant  valvular  dis-
ease  (n  =  9),  poor  image  quality  (n  =  17),  and  incomplete
data  (n  =  6).  Thus,  we  measured  PF  volumes  from  CT
images  and  examined  echocardiographic  parameters  in
229  consecutive  patients.  The  study  was  approved  by  the
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M345
ivariate  logistic  regression  analysis  indicated  that  PF  volume
presence  of  LVDD  (odds  ratio:  2.00  per  100  cm3 increase  in  PF
age,  gender,  abdominal  obesity,  hypertension,  and  diabetes.
niﬁcantly  associated  with  LVDD,  independent  of  other  factors
 PF  may  be  implicated  in  the  pathogenesis  of  LVDD  in  patients
ology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
thics  review  committee  of  our  institution  and  a  signed
nformed  consent  was  obtained  from  each  patient  before
articipation.  This  study  was  registered  at  UMIN  proto-
ol  registration  system  with  the  identiﬁcation  number
MIN000003361.
ardiac  CT  scan  protocol
he  64-detector  CT  (Brilliance-64,  Phillips  Medical  Sys-
ems,  Cleveland,  OH,  USA)  was  used  with  the  following
arameters:  detector  collimation  64  mm  ×  0.625  mm,  table
eed  19.7  mm/s,  0.2  beam  pitch,  rotation  time  420  ms,
ube  current  429  mA,  and  voltage  120  kVp,  as  reported
reviously  [7].  Reconstruction  sets  at  75%  of  the  cardiac
ycle  or  at  a  particular  optimal  phase  were  prepared  from
he  raw  data  ﬁles.  The  contrast  material  (Omnipaque-
50;  Daiichi-Sankyo  Pharmaceutical,  Tokyo,  Japan)  was
dministered  using  a  mechanical  power  injector  through
 20-gauge  cannula  inserted  into  the  antecubital  vein.
o  minimize  differences  in  arterial  enhancement  across
atients,  we  used  a  body-weight-tailored  contrast  mate-
ial  dose  (0.7  mL/kg)  and  a ﬁxed  injection  duration  (9  s)
13]. An  oral  -blocker  (metoprolol,  20  mg)  was  adminis-
ered  1  h  prior  to  CT  imaging,  and  nitroglycerin  (0.3  mg)
as  administrated  immediately  prior  to  CT  imaging.  The
econstructed  CT  image  data  were  transferred  to  a  work-
tation  for  post-processing  (ZIO  M900,  Amin/ZIO,  Tokyo,
apan).
ardiac  CT  image  analysis
F  volume  was  measured  three-dimensionally  in  all  patients
sing  contrast-enhanced  images,  as  reported  previously
7].  A  predeﬁned  image  display  setting  was  used  [window
idth  =  150  Hounsﬁeld  units  (HU),  window  center  =  −120  HU]
o  identify  pixels  that  correspond  to  fat  tissue  [14]. The
eaders,  who  were  blinded  to  the  clinical  results,  trimmed
long  the  pericardial  sac  using  axial,  coronal,  and  sagittal
lices  and  volume-rendered  images.  PF  was  deﬁned  to  be
ny  adipose  tissue  located  within  the  pericardial  sac  (Fig.  1).
 slice  1  cm  above  the  most  cranial  slice  including  the  left
nterior  descending  coronary  artery  was  deﬁned  to  be  the
uperior  border  of  the  PF.
Three  major  coronary  arteries  were  analyzed  visually  and
uantitatively  by  contrast-enhanced  coronary  CT  angiogra-
hy.  Coronary  artery  disease  was  deﬁned  to  be  ≥75%  stenosis
according  to  the  American  Heart  Association  classiﬁcation)
n  conventional  coronary  angiography  (n  =  136)  analyzed
uantitatively  by  coronary  angiography  software  (CAAS,  Pie
edical  Imaging,  Maastricht,  Netherlands)  or  ≥50%  luminal
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Figure  1  Representative  computed  tomography  (CT)  images  of  a  55-year-old  male  patient  with  hypertension,  dyslipidemia,  and
diabetes. Red  area  is  the  pericardial  fat  (PF)  within  the  pericardial  sac  quantiﬁed  three-dimensionally  by  CT.  The  axial  (A),  saggital
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tB), and  coronal  (C)  slice  of  the  PF.  His  PF  volume  was  265  cm3
his ﬁgure  legend,  the  reader  is  referred  to  the  web  version  of  
arrowing  on  CT  images  in  patients  without  conventional
oronary  angiography  (n  =  98).
chocardiography
or  each  patient,  echocardiography  was  performed  by
 specialized  echocardiologist.  The  cavity  dimension  and
all  thickness  were  measured  in  a  parasternal  long  axis
iew.  Left  ventricular  mass  was  estimated  using  the  for-
ula  recommended  by  guidelines  [15]. Measurement  of
VEF  was  performed  in  biplane  apical  (2-and  4-chamber)
iews  using  a  modiﬁed  Simpson’s  method.  The  pulsed
oppler  sample  volume  was  positioned  at  the  opened
eaﬂet  tips  of  mitral  valve.  Early  and  late  diastolic  peak
ow  velocity  and  E-wave  deceleration  time  were  measured
y  transmitral  Doppler  imaging.  The  ratio  of  transmitral
oppler  early  ﬁlling  velocity  to  tissue  Doppler  early  dias-
olic  mitral  annular  velocity  (E/e′)  was  also  measured.  LVDD
as  deﬁned  as  the  tissue  Doppler  oriented  criterion  using
/e′ >  10  [16—18].
ssessment  of  risk  factors  and  covariates
besity  was  deﬁned  as  a  body  mass  index  of  ≥25  kg/m2.
bdominal  obesity  was  deﬁned  as  a  waist  circumference
f  ≥85  cm  for  Japanese  males  and  ≥90  cm  for  Japanese
emales  [19]. Blood  was  drawn  after  an  overnight  fast.  Dia-
etes  mellitus  was  diagnosed  based  on  the  criteria  set  by  the
orld  Health  Organization  or  the  use  of  hypoglycemic  agents
r  insulin.  Hypertension  was  deﬁned  as  a  systolic  blood  pres-
ure  ≥140  mmHg,  a  diastolic  blood  pressure  ≥90  mmHg,  or
he  use  of  an  antihypertensive  treatment.  The  estimated
lomerular  ﬁltration  rate  was  calculated  using  a  modiﬁed
ormula  from  the  Modiﬁcation  of  Diet  in  Renal  Disease  study
quation,  which  was  proposed  by  the  Japanese  Society  of
ephrology  [20]. Metabolic  syndrome  was  diagnosed  accord-
ng  to  the  modiﬁed  Adult  Treatment  Panel  III  criteria,  which
nclude  the  waist  circumference  cut-off  values  mentioned
bove  and  the  presence  of  three  or  more  metabolic  abnor-
alities.
c
t
ﬁ
m E/e′ was  15.  (For  interpretation  of  the  references  to  color  in
rticle.)
tatistical  analysis
ata  are  expressed  as  mean  ±  standard  deviation.  Differ-
nces  in  risk  factors  and  adiposity  traits  in  patients  with  or
ithout  LVDD  were  assessed.  Differences  between  continu-
us  variables  were  analyzed  by  the  unpaired  Student’s  t-test
r  the  Mann-Whitney  U  test,  as  appropriate.  Differences  in
ategorical  variables  were  analyzed  by  the  chi-square  test.
ifferences  in  PF  volumes  in  patients  with  or  without  LVDD
ere  analyzed  by  the  unpaired  Student’s  t-test.  Pearson
orrelations  and  stepwise  multivariate  regression  analysis
mong  PF  volume,  metabolic  risk  factors,  and  echocardio-
raphic  parameters  associated  with  LVDD  were  performed.
nivariate  and  multivariate  backward  logistic  regression
nalyses  were  used  to  assess  the  relationships  among  the
resence  of  LVDD,  PF  volume,  and  other  risk  factors.  We
lso  tested  the  signiﬁcant  association  between  PF  volumes
nd  LVDD  in  multivariate  logistic  regression  analyses  using
orced  inclusion  models  of  the  following  parameters:  model-
,  age  and  gender;  model-2,  age,  gender,  hypertension,
nd  diabetes;  model-3,  age,  gender,  hypertension,  diabetes,
nd  abdominal  obesity.  The  Hosmer—Lemeshow  statistic  was
pplied  to  assess  model  calibration.  A  p-value  of  <0.05
enoted  statistical  signiﬁcance,  and  all  tests  were  two-
ailed.  Variables  were  log-transformed  if  they  had  a  skewed
istribution.  All  analyses  were  performed  using  SPSS  17.0J
or  Windows  (SPSS  Inc.,  Tokyo,  Japan).
esults
tudy  sample  characteristics
able  1  shows  the  characteristics  of  the  participating
atients  (n  =  229).  Patients  with  LVDD  (n  =  141)  had  a  higher
ge,  body  mass  index,  waist  circumference,  systolic  blood
ressure,  fasting  plasma  glucose,  and  hemoglobin  A1c,
ower  estimated  glomerular  ﬁltration  rate;  were  more  likely
o  have  hypertension,  diabetes,  metabolic  syndrome,  and
oronary  artery  disease;  and  used  aspirin  more  frequently
han  those  without  LVDD  (n  =  88).  In  the  echocardiographic
ndings,  patients  with  LVDD  had  a  higher  left  ventricular
ass  index  and  left  atrial  diameter.
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Table  1  Characteristics  of  patients  with  and  without  LVDD.
Parameters  Total  LVDD  (+)  LVDD  (−)  p-Value
Number  229  141  88
Age, years  67  (12)  69  (10)  63  (12)  <0.001
Male gender,  %  59  59  60  0.89
Obesity, %  30  33  26  0.37
Body mass  index,  kg/m2 23.5  (3.3)  23.7  (3.2)  23.1  (3.6)  0.16
Abdominal obesity,  % 56  60  50  0.17
Waist circumferences,  cm 86.8  (9.3) 87.9  (8.6)  85.1  (10.0)  0.03
Hypertension,  % 74 80 64  <0.01
Systolic blood  pressure,  mmHg 131  (20) 134  (20) 126  (18) <0.01
Diastolic blood  pressure,  mmHg 74  (12) 73  (13) 74  (12) 0.62
Dyslipidemia,  %  65  69  58  0.12
Total cholesterol,  mg/dL  187  (33)  187  (33)  190  (34)  0.83
LDL cholesterol,  mg/dL  110  (30)  108  (32)  112  (32)  0.58
HDL cholesterol,  mg/dL  55  (17)  54  (16)  58  (19)  0.14
Triglycerides,  mg/dLa 104  (74—149)  107  (77—156)  101  (71—146)  0.14
Diabetes mellitus,  %  35  42  23  <0.01
Fasting plasma  glucose,  mg/dL  98  (26)  102  (29)  93  (19)  <0.01
Hemoglobin  A1c,  %a 5.8  (5.5—6.4)  5.9  (5.6—6.6)  5.7  (5.4—6.3)  0.02
Metabolic syndrome,  %  43  49  33  0.02
Current smoker,  %  20  18  23  0.50
Estimated GFR,  mL/min/1.73  m2 71  (19)  68  (20)  76  (17)  <0.01
B-type natriuretic  peptide,  pg/mLa 29  (15—63)  34  (15—71)  26  (14—46)  0.07
Medications
Statins, % 37 42  30  0.07
Aspirin, % 48  54  38  0.02
-Blockers, %  24  22  26  0.52
ACE inhibitors  or  ARBs,  % 45  50  38  0.08
Thiazolidinediones,  % 6 6  5  0.77
Atrial ﬁbrillation,  % 18 16 21  0.48
Coronary angiography,  % 58 65  48  0.01
Coronary artery  disease,  % 40 46 31  0.03
Echocardiography
LVEF, % 64  (6) 64  (6) 64  (6) 1.00
LV mass  index,  g/m2 105  (27) 109  (27) 99  (25) <0.01
Left atrial  diameter,  mm  38  (6)  38  (5)  36  (6)  <0.01
E/Aa 0.8  (0.7—1.1)  0.8  (0.7—1.1)  0.8  (0.7—1.1)  0.98
E-wave deceleration  time,  ms  221  (65)  227  (71)  211  (53)  0.06
Data are mean (standard deviation) or number (percentage).
LVDD, left ventricular diastolic dysfunction; LDL, low-density lipoprotein; HDL, high-density lipoprotein; GFR, glomerular ﬁltration rate;
ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; LVEF, left ventricular ejection fraction; LV, left ventricle; E/A,
v
l
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1
Fearly/late diastolic peak ﬂow velocity ratio.
a Median and 25th to 75th percentiles.
Correlation  between  PF  volume,  risk  factors,  and
LVDD
PF  volume  correlated  positively  with  body  mass  index
(r  =  0.51,  p  <  0.001),  waist  circumferences  (r  =  0.56,
p  <  0.001),  systolic  blood  pressure  (r  =  0.16,  p  =  0.02),  log
hemoglobin  A1c  (r  =  0.23,  p  <  0.001),  and  log  triglyceride
(r  =  0.32,  p  <  0.001),  and  negatively  with  high-density
lipoprotein  cholesterol  (r  =  −0.32,  p  <  0.001).  Multiple
stepwise  regression  analysis  identiﬁed  age  (beta  =  0.13,
p  =  0.02)  and  waist  circumference  (beta  =  0.56,  p  <  0.001)  as
signiﬁcant  and  independent  correlates  with  PF  volume.  PF
volume  correlated  signiﬁcantly  with  E/e′ (r  =  0.21,  p  <  0.01;
Fig.  2A).  PF  volume  also  correlated  positively  with  left
U
r
tentricular  mass  index  (r  =  0.23,  p  <  0.001;  Fig.  2B)  and
eft  atrial  diameter  (r  =  0.32,  p  <  0.001;  Fig.  2C),  nega-
ively  with  the  log  early/late  diastolic  peak  ﬂow  velocity
atio  (r  =  −0.14,  p  =  0.03),  but  not  with  LVEF  (r  =  −0.07,
 =  0.31).  PF  volume  was  larger  in  patients  with  LVDD
n  =  141;  184  ±  61  cm3)  than  those  without  LVDD  (n  =  88;
54  ±  58  cm3, p  <  0.001;  Fig.  2D).
actors  associated  with  LVDDnivariate  logistic  regression  analysis  found  signiﬁcant
elationships  between  the  presence  of  LVDD  and  age,  hyper-
ension,  diabetes,  estimated  glomerular  ﬁltration  rate,  left
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Figure  2  Correlation  between  pericardial  fat  (PF)  volume  and  left  ventricular  diastolic  dysfunction  (LVDD).  Correlation  between
PF volume  and  echocardiographic  parameters:  E/e′ (A),  left  ventricular  mass  index  (B),  and  left  atrial  diameter  (C).  PF  volume  had  a
signiﬁcant positive  correlation  with  E/e′ (r  =  0.21,  p  <  0.01),  left  ventricular  mass  index  (r  =  0.23,  p  <  0.001),  and  left  atrial  diameter
(r =  0.32,  p  <  0.001).  Filled  and  open  circles  indicate  patients  with  and  without  LVDD,  respectively.  (D)  PF  volume  in  patients  with  or
without LVDD.  Bar  graph  indicates  mean  +  standard  deviation.  PF  volume  was  signiﬁcantly  larger  in  patients  with  LVDD  (184  ±  61  cm3)
than in  those  without  LVDD  (154  ±  58  cm3,  p  <  0.001).
Table  2  Univariate  and  multivariate  backward  stepwise  logistic  regression  analyses  of  pericardial  fat  volume  and  risk  factors
associated with  the  presence  of  LVDD.
Factors  Univariate  Multivariate
OR  (95%CI)  p-Value  OR  (95%CI)  p-Value
Age  (per  10  years)  1.60  (1.25—2.04)  <0.001  1.50  (1.16—1.95)  0.02
Male gender  (yes)  0.95  (0.55—1.63)  0.84  Not  selected
Body mass  index  (per  kg/m2)  1.06  (0.98—1.15)  0.16  Not  selected
Abdominal obesity  (yes)  1.47  (0.86—2.52)  0.16  Not  selected
Hypertension  (yes)  2.30  (1.27—4.20)  <0.01  Not  selected
Dyslipidemia  (yes)  1.60  (0.92—2.78)  0.10  Not  selected
Diabetes mellitus  (yes)  2.44  (1.34—4.46)  <0.01  2.24  (1.16—4.33)  0.02
Coronary artery  disease  (yes)  1.25  (0.89—1.75)  0.20  Not  selected
Estimated GFR  (per  10  mL/min/1.73  m2)  0.81  (0.70—0.94)  <0.01  Not  selected
B-type natriuretic  peptide  (per  100  pg/mL)  1.73  (0.95—3.18)  0.07  Not  selected
LVEF (per  %)  1.00  (0.96—1.04)  0.99  Not  selected
LV mass  index  (per  g/m2)  1.02  (1.00—1.03)  <0.01  Not  selected
PF volumes  (per  100  cm3)  2.36  (1.46—3.80)  <0.001  2.06  (1.22—3.47)  <0.01
LVDD, left ventricular diastolic dysfunction; OR, odds ratio; GFR, glomerular ﬁltration rate; LVEF, left ventricular ejection fraction; LV,
left ventricle; PF, pericardial fat.
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Table  3  Multivariate-adjusted  odds  ratio  for  the  presence  of  LVDD.
Model  adjustments  Model  1  Model  2  Model  3
Odds  ratio  (95%CI)  p-Value  Odds  ratio  (95%CI)  p-Value  Odds  ratio  (95%CI)  p-Value
Age  (per  10  years) 1.54  (1.20—1.97)  <0.01  1.55  (1.20—2.00)  <0.01  1.54  (1.19—1.99)  <0.01
Male gender  0.77  (0.42—1.41)  0.39  0.74  (0.40—1.37)  0.33  0.74  (0.40—1.38)  0.35
Hypertension  —  —  1.35  (0.69—2.65)  0.38  1.36  (0.70—2.67)  0.37
Diabetes mellitus — — 2.02  (1.04—3.92)  0.04  2.09  (1.06—4.12)  0.03
Abdominal obesity — — — —  1.23  (0.63—2.40)  0.54
PF volume  (per  100  cm3)  2.38  (1.43—3.97)  <0.01  1.95  (1.13—3.34)  0.02  2.09  (1.15—3.79)  0.02
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dLVDD, left ventricular diastolic dysfunction; CI, conﬁdence interva
ventricular  mass  index,  and  PF  volume  (Table  2).  Multivari-
ate  backward  logistic  regression  analysis  identiﬁed  age  [odds
ratio  (OR):  1.50,  95%  conﬁdence  interval  (CI):  1.16—1.95
per  10  years,  p  =  0.02],  the  presence  of  diabetes  (OR:  2.24,
95%  CI:  1.16—4.33,  p  =  0.02),  and  PF  volume  (OR:  2.06  per
100  cm3,  95%  CI:  1.22—3.47,  p  <  0.01)  as  signiﬁcant  and
independent  factors  associated  with  the  presence  of  LVDD.
This  model  was  reliable  (p  =  0.17  by  the  Hosmer—Lemeshow
test).  In  the  forced  entry  models,  we  conﬁrmed  the  signif-
icant  association  between  PF  volume  and  the  presence  of
LVDD  (OR:  2.09  per  100  cm3,  95%  CI:  1.15—3.79,  p  =  0.02)
independent  of  age,  gender,  hypertension,  diabetes,  and
abdominal  obesity  (Table  3).  This  model  was  also  reliable
(p  =  0.71  by  the  Hosmer—Lemeshow  test).
Discussion
The  present  study  demonstrates  that  PF  volumes  correlate
signiﬁcantly  with  E/e′,  indicating  the  association  between
PF  volumes  and  LVDD.  Furthermore,  multivariate  analysis
indicated  that  PF  volume  correlates  signiﬁcantly  with  the
presence  of  LVDD,  independent  of  other  risk  factors  such  as
age,  gender,  hypertension,  diabetes,  or  abdominal  obesity.
PF  has  been  reported  to  correlate  with  left  atrial  dimen-
sions  [12]  and  left  ventricular  diastolic  ﬁlling  [21], neither
of  which  are  recommended  as  ﬁrst-line  diagnostic  parame-
ters  for  LVDD  [22]. However,  recent  guidelines  recommend
the  evaluation  of  tissue  Doppler  E/e′ in  the  assessment  of
LVDD  [22]. To  our  knowledge,  the  present  study  is  the  ﬁrst
to  report  the  signiﬁcant  association  between  PF  volume  and
LVDD  using  tissue  Doppler  echocardiography.
Potential  mechanisms
The  potential  mechanisms  underlying  the  direct  correla-
tion  between  PF  volumes  and  LVDD  are  mechanical  and
paracrine  processes.  Compression  of  PF  on  the  myocardium
may  induce  LVDD  [12]  by  disturbing  the  dilation  of  the
left  ventricle  and  impairing  cardiac  ﬁlling  through  a  patho-
physiology  similar  to  the  thickening  of  the  pericardium  in
constrictive  pericarditis  [23]. Previous  studies  also  reported
the  paracrine  effects  of  PF.  Pericardial  and  perivascu-
lar  fat,  but  not  subcutaneous  fat,  contain  high  levels  of
various  cytokines  [24]  that  may  induce  inﬂammation  and
increase  subsequent  collagen  turnover,  leading  to  LVDD
[25].  Myocardial  dysfunction  may  be  induced  by  a  loss
d
c
c
r, pericardial fat.
f  adiponectin  secretion  or  reduced  nitric  oxide  synthase
ctivity  in  perivascular  fat  [26]. Both  may  act  directly
n  cardiomyocytes  [27]  and  indirectly  through  impaired
icrovascular  relaxation  in  the  myocardium  [28]. Thus,
t  is  possible  that  a  similar  mechanism  operates  through
aracrine  processes.  The  systemic  effects  of  obesity,  dia-
etes,  and  other  metabolic  disorders  on  LVDD  have  also  been
escribed  in  previous  studies  [5].
PF  has  been  observed  inside  and  outside  the  pericardial
ac,  which  was  also  reported  to  be  associated  with  aortic
alciﬁcation  [14]. The  PF  outside  the  sac  potentially  has
ome  effects  on  left  ventricular  function.  We  measured  PF
olume  by  trimming  along  the  pericardial  sac  using  axial,
oronal,  and  saggital  slices  and  volume-rendered  images  by
4-slice  CT.  In  the  present  study,  we  could  not  precisely  dis-
inguish  PF  distribution  inside  or  outside  the  sac.  Further
tudies  might  be  required  to  determine  the  effects  of  the
F  outside  the  sac  on  LVDD.
ardiac  CT  and  echocardiography
e  originally  quantiﬁed  PF  volume  three-dimensionally
sing  multislice  CT.  This  technique  yielded  highly  repro-
ucible  measurements  (CV  =  7.1%  and  8.9%  for  inter-  and
ntra-observer  variability,  respectively)  [7,29]. In addition,
4-slice  CT  is  commonly  used  in  cardiovascular  clinical  prac-
ice  in  Japan.
Noninvasive  diagnostic  evidence  for  LVDD  is  preferably
erived  from  myocardial  tissue  Doppler.  E/e′ is  reported  to
orrelate  closely  with  LV  ﬁlling  pressure,  and  this  correlation
as  been  conﬁrmed  in  patients  with  pseudo-normal  mitral
alve  ﬂow  velocity  ﬁlling  patterns  [22]. We  deﬁned  LVDD
imply  as  E/e′ >  10  according  to  the  previously  described  cut-
ff  value  [16,17]  partially  because  of  lack  of  data  concerning
uration  of  reverse  pulmonary  vein  atrial  systole  ﬂow,  dura-
ion  of  mitral  valve  atrial  wave  ﬂow,  and  left  atrium  volume
ndex  used  in  recent  guidelines  [22].
imitations
he  clinical  study  design  was  cross-sectional,  and  the  results
o  not  imply  causality.  Because  the  subjects  were  not  ran-
omly  selected  but  rather  inpatients  suspected  to  have
oronary  artery  disease,  they  were  more  likely  to  have
oronary  artery  disease  than  the  general  population,  their
isk  factors  were  considered  to  have  been  modiﬁed  by
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[50  
edications,  and  some  selection  bias  may  inﬂuence  the
esult  of  the  present  study  (B-type  natriuretic  peptide  level
nd  left  ventricle  mass  index  are  less  than  expected).  The
ack  of  data  regarding  the  extent  of  coronary  artery  dis-
ase  severity  is  also  a  limitation  because  it  may  largely
ffect  LVDD.  E/e′ is  a  marker  of  increased  left  ventricular
lling  pressure,  but  may  occur  due  to  reasons  other  than  pri-
ary  myocardial  disease,  affecting  the  ﬁndings.  The  value
f  E/e′ depends  on  the  technician’s  experience.  Because  it
epends  also  on  ﬂuid  status  and  medications,  the  lack  of
ata  about  time  frame  between  CT  and  echocardiography
ay  also  be  a  limitation.  The  lack  of  data  about  duration
f  reverse  pulmonary  vein  atrial  systole  ﬂow,  duration  of
itral  valve  atrial  wave  ﬂow,  and  left  atrial  volume  index,
hich  are  used  in  recent  guidelines  to  diagnose  LVDD,  is
lso  a  major  limitation  on  deﬁning  LVDD.  We  have  no  data
bout  the  distribution  of  body  fat  (especially  abdominal
isceral  fat  and  fat  outside  the  pericardial  sac)  but  only
ave  waist  circumference  though  this  would  help  to  get
ore  insight  into  the  differential  pathophysiologic  mecha-
isms.  The  correlations  between  PF  volume  and  parameters
f  LVDD  (r  =  0.21—0.32)  are  weak,  although  statistically  sig-
iﬁcant,  so  clinical  signiﬁcance  of  these  correlations  should
e  considered  cautiously.  The  multivariate  statistical  models
ncorporated  both  abdominal  obesity  and  PF  volume,  whose
lose  correlation  may  affect  the  results  of  the  analyses.
linical  implications
n  settings  where  the  causality  between  PF  volume  and  LVDD
s  demonstrated  by  a  prospective  study,  PF  volume  may  serve
s  a  potential  therapeutic  target  to  prevent  LVDD  or  heart
ailure  in  patients  with  normal  EF.  PF  volume  measurement
ay  be  useful  in  selecting  therapeutic  strategies.  For  exam-
le,  thiazolidinediones  have  been  reported  to  increase  PF
30]  and  such  medications  may  not  be  beneﬁcial  in  patients
ith  LVDD.  It  may  also  be  useful  to  assess  the  effect  of
ow-calorie  diet  on  PF  volume  [31]  or  the  effect  of  surgical
emoval  [32]  of  PF  on  LVDD.
onclusions
he  present  study  demonstrated  that  PF  volume  correlated
igniﬁcantly  with  LVDD,  independent  of  other  risk  factors
uch  as  age,  gender,  diabetes,  hypertension,  or  abdominal
besity.  PF  may  play  a  role  in  the  pathogenesis  of  LVDD.
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